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The MVM NS2 proteins are required for viral replication in cells of its normal murine host, but are dispensable in transformed human 324K
cells. Alternate splicing at the minor intron controls synthesis of three forms of this protein, which differ in their C-terminal hexapeptides and in
their relative abundance, with NS2P and NS2Y, the predominant isoforms, being expressed at a 5:1 ratio. Mutant genomes were constructed with
premature termination codons in the C-terminal exons of either NS2P or NS2Y, which resulted in their failure to accumulate in vivo. To modulate
their expression levels, we also introduced a mutation at the putative splice branch point of the large intron, dubbed NS2lo, that reduced total NS2
expression in murine A9 cells such that NS2P accumulated to approximately half the level normally seen for NS2Y. All mutants replicated
productively in human 324K cells. In A9 cells, NS2Y− mutants replicated like wildtype, and the NS2lo mutants expressed NS1 and replicated
duplex viral DNA like wildtype, although their progeny single-strand DNA synthesis was reduced. However, while NS2P− and NS2-null viruses
initiated infection efficiently in A9 cells, they gave diminished NS1 levels, and viral macromolecular synthesis appeared to become paralyzed
shortly after the onset of viral duplex DNA amplification, such that no progeny single-strand DNA could be detected. Thus, the NS2P isoform,
even when expressed at a level lower than that of NS2Y, performs a critical role in infection of A9 cells that cannot be accomplished by the NS2Y
isoform alone.
© 2006 Elsevier Inc. All rights reserved.Keywords: Parvovirus; Non-structural proteins; NS2P; NS2Y; DNA replication; Progeny synthesisIntroduction
Minute virus of mice (MVM) is a small nonenveloped
icosahedral virus from the family Parvoviridae, with a 5 kb
single-stranded linear DNA genome that encodes two non-
structural proteins. The multifunctional 83 kDa NS1 polypep-
tide has site-specific DNA binding, nicking, ATPase, and
helicase activities that are essential for viral DNA replication
(Cotmore and Tattersall, 1995), and also has a role in
modulating viral transcriptional regulation (Doerig et al.,
1988, 1990; Lorson et al., 1996) and aspects of the host cell
environment (Anouja et al., 1997; Op de Beeck and Caillet-
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doi:10.1016/j.virol.2006.01.039are less well defined, and these proteins are dispensable for
productive replication in certain transformed human cells, such
as 324K (Naeger et al., 1990). There are three distinct forms of
this small polypeptide, NS2P, NS2Y, and NS2L, generated by
alternative splicing at the minor viral intron, which differ only in
their extreme C-terminal hexapeptides, and in their relative
abundance (Cotmore and Tattersall, 1990; Morgan and Ward,
1986). In A9 mouse cells, NS2P, the major isoform, and NS2Y,
the next most abundant form, are expressed at an approximately
five to one ratio, while NS2L expression is several-fold lower
still. As illustrated in Fig. 1, the alternative splice arrangements
at this minor intron that generate these NS2 isoforms are critical
for the generation the two capsid proteins, of which VP2 is the
more abundant. The minor species, VP1, shares all of the
sequence of VP2, has a unique 142 amino acid N-terminal
extension, and while not being required for assembly and
packaging, is essential for viral entry (Tullis et al., 1993). While
Fig. 1. Mutagenesis strategy in NS2. Top inset. MVMp DNA sequence of region adjacent to the major intron 3′ splice acceptor (stippled arrow) showing the protein
coding sequence for amino acids 570 to 581 of NS1, as well as the second exon of NS2, which initiates at the major intron acceptor site. An A to G mutation (shown in
box above the wildtype sequence) was introduced at nucleotide position 1970 in order to decrease the splicing efficiency within this region, thereby decreasing overall
NS2 expression levels. Middle panel. Line diagram of the single-stranded MVM genome. P4 and P38 represent the positions of the nonstructural and capsid gene
promoters, respectively. The three size classes of mRNAs (R1, R2, and R3) are shown, and the exons of the proteins they specify are represented by boxes, shaded
according to the reading frame in which they are encoded. The R2 transcripts encode three distinct populations of the nonstructural protein, NS2, as a result of alternate
splicing events within the minor intron, which is shown in greater detail in the bottom inset. Bottom inset. DNA sequence within the minor intron of NS2 containing the
major and minor 5′ splice donor sites, at nucleotide positions 2280/1 and 2316/7, respectively, and 3′ acceptor sites, at nucleotide positions 2376/7 and 2398/9,
respectively, as indicated by stippled arrows. Differential splicing between these sites gives rise to VP1 and VP2, as well as three distinct isoforms of NS2, as indicated
by the dotted lines. Amber termination mutations are shown in boxes above the wildtype sequence and were introduced into the C-terminal specific exons of NS2P or
NS2Y as described in the Materials and methods.
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alternative splice arrangement that is essential for capsid
production, it is also possible that they have evolved to serve
unique roles in the viral life cycle.
All NS2 subtypes have an 84 amino acid N-terminal domain
in common with NS1, spliced to a central 98 amino acid exon
that they share with each other, only differing in their extreme C-
termini (Cotmore and Tattersall, 1986, 1990; Jongeneel et al.,
1986; Morgan and Ward, 1986). In addition to these structural
similarities, each of the NS2 species is posttranslationally
modified, existing in both phosphorylated and nonphosphory-
lated forms, and while most forms of the protein are found
predominantly in the cytoplasm, phosphorylated forms are
exclusively cytoplasmic (Cotmore and Tattersall, 1990). NS2 is
the predominant virally coded protein expressed early in infected
cell cultures, and all three isoforms exhibit similar short half-
lives, of approximately 1 h. Later in infection, their expressionlevels rapidly decline due to a combination of their relatively fast
turnover rates and reduced P4 viral promoter activity (Clemens
and Pintel, 1988; Cotmore and Tattersall, 1990; Schoborg and
Pintel, 1991). However, since these features are shared by all
NS2 isoforms, they are likely determined by common
sequences, rather than by their unique C-terminal peptides.
Although dispensable for productive infection in a variety of
nonmurine cell lines, in cells from its natural murine host, NS2 is
required for viral growth (Cater and Pintel, 1992; Naeger et al.,
1990). Previous studies have shown that mutants that fail to
accumulate NS2 have a primary defect in viral DNA
amplification in mouse fibroblasts, with replicative form DNA
being reduced to 5% that of wildtype, while single strand
progeny DNA is undetectable (Cotmore et al., 1997; Naeger et
al., 1993). Furthermore, these mutants also possess a defect in
capsid assembly that is associated with enhanced VP protein
turnover and eventually leads to diminished protein synthesis
Fig. 2. Viral protein expression profile in human 324K cells. Asynchronous
cultures of transformed human 324K cells were infected at a multiplicity of 3000
genomes per cell. At 2.5 h postinfection, the inoculum was removed and
medium containing neuraminidase was added. Uninfected controls and infected
cells were harvested 24 h postinfection. Cell pellets were processed for protein
analysis following standard SDS-PAGE and immunoblot protocols. Viral
nonstructural proteins were detected using polyclonal antibodies directed
against the C-terminal hexapeptide sequences specific for NS2P (top panel) or
NS2Y (middle panel), or the common amino-terminus of NS1/2 (bottom panel).
384 Z. Ruiz et al. / Virology 349 (2006) 382–395(Cotmore et al., 1997). However, there is as yet no evidence for
the direct involvement of NS2 in any of the viral synthetic
pathways, leading to the tentative conclusion that these proteins
function predominantly by modifying the host environment in
murine cells. Accordingly, various studies have sought to
explore NS2 function by identifying interacting host cell
proteins. Thus far, such studies have failed to reveal mechanistic
details of the essential role(s) of NS2 in murine cells, but they do
suggest that these proteins havemultiple functions. For example,
NS2 coimmunoprecipitates with two members of the 14-3-3
family of proteins in both permissive and nonpermissive cells of
various origins (Brockhaus et al., 1996), but this molecular
interaction is not essential for the viral life cycle in mouse cells
because it can be disrupted, by mutation of a critical
phosphorylation site at NS2 residue T149 to alanine, without
seriously impairing viral viability in these cells (reviewed in
Nuesch, 2005). NS2 has also been shown to interact with the
nuclear export protein Crm1 (Bodendorf et al., 1999; Ohshima et
al., 1999), and NS2mutants in which this interaction is disrupted
display a late defect, most likely due to their failure to efficiently
export progeny virions from the nucleus (Miller and Pintel,
2002; Eichwald et al., 2002). Thus, while the Crm1 interaction is
important for promoting nuclear egress of progeny virus, it is not
absolutely required for the early steps in the MVM replication
cycle that allow efficient duplex DNA amplification. Finally, the
Survival of Motor Neuron (SMN) protein interacts with both
NS2 and NS1, through the common N-terminal exon shared by
both of these nonstructural proteins (Young et al., 2002b). The
significance of this interaction is currently unknown, although
SMN has been shown to colocalize with NS1 within large
nuclear structures known as SMN-associated autonomous
parvovirus replication bodies (SAABs) that form late in
infection (Young et al., 2002a). While the significance of
SAABs in infection has not yet been determined, their formation
is known to be independent of the expression of NS2 (Young et
al., 2005). The failure, to date, to identify protein:protein
interactions with host cell factors that are critical for execution of
the essential function(s) of NS2 in murine cells, may indicate
that such interactions are too transient, or of too low an affinity,
to be picked up by these techniques.
In the current study, we sought to define which, if any, of the
NS2 subtypes were necessary and sufficient to support MVM
replication in mouse cells, using specific NS2P or NS2Y
knockout mutants. Our results indicate that the C-terminus of
the more abundant NS2P splice variant has evolved to perform
an essential function required during infection of murine cells,
and that once this requirement has been met, the overall level of
NS2 further modulates the extent of MVM progeny formation.
Results
Mutations in the C-terminal exons of NS2P or NS2Y
specifically abolish accumulation of that isoform in 324K cells
The use of alternative major and minor splice donors and
acceptors at the small MVM intron creates NS2P and NS2Y
isoforms that differ solely by 6 amino acids at their extreme C-termini, NS2 residues 183–188, as detailed at the bottom of Fig.
1. Amber termination codons were engineered into these exons
in an infectious plasmid clone of MVM, replacing tryptophan
residue W187 in NS2P, to create an NS2P knock-out denoted
“P−/Y+”, and tyrosine residue Y183 in NS2Y, to create the
NS2Y knock-out called “P+/Y−”. NS2P and NS2Y differ in
their expression levels, with approximately 5 copies of NS2P
accumulating per copy of NS2Y throughout the course of
infection of mouse cells by the wildtype (Cotmore and
Tattersall, 1990). We sought to compensate for any potential
effects due to the higher dosage of NS2P in the NS2Y knock-
out mutant by introducing an A-to-G mutation at MVM
nucleotide 1970, as shown at the top of Fig. 1. This mutation has
previously been shown to influence the relative accumulation of
NS2 and NS1 (D'Abramo et al., 2005; Choi et al., 2005), and
impairs NS2 accumulation between 2- and 10-fold, as measured
24 h postinfection at high input multiplicity (104 genomes per
cell), the exact level of depletion depending on the particular
cell line infected (D'Abramo et al., 2005). This mutation was
introduced both into the wildtype background, creating a virus
we called “Plo/Ylo” and into the NS2Y knock-out mutant,
creating “Plo/Y−”. Finally, we used an “NS2-null” mutant,
published previously (Cotmore et al., 1997), in which an amber
codon replaces phenylalanine at NS2 residue 86, which is the
first amino acid in the NS2 second exon.
Virus stocks were generated by transfecting infectious clone
DNA into 324K cells. Resulting virions were purified, nuclease-
digested, and their genomes quantitated by Southern transfer
following electrophoresis through a denaturing agarose gel. We
then examined the ability of these viruses to express viral
nonstructural proteins 24 h postinfection in the transformed
human cell line, 324K. Antipeptide antibodies, directed against
the specific C-termini of NS2P or NS2Y (Fig. 2, top two
panels), reacted with NS2 species expressed in cells infected
Fig. 3. Infection initiation and viral expansion assays in human 324K cells. (A)
Asynchronous cultures of transformed human 324K cells were infected with
NS2-null [◼], NS2P−/Y+ [◊], NS2P+/Y− [□], NS2P+/Y+ (wildtype) [O], NS2Plo/
Y− [○], or NS2Plo/Ylo [•] viruses at a range of multiplicities between 30 and
75,000 genome equivalents per cell, in the presence of neuraminidase in order to
maintain single round infection conditions. Cells were fixed 20 h postinfection
and stained with a mouse monoclonal antibody directed against the NS1 protein.
The percentages of infected cells were calculated as the ratio of NS1-positive
nuclei per total number of DAPI-stained nuclei. (B) Asynchronously growing
324K cells were infected at a multiplicity of 30 genome equivalents per cell. At
18 h postinfection, the inoculum was removed and the cells were incubated with
medium in the presence or absence of neutralizing antibody. At 72 h
postinfection, cells were fixed and processed for indirect immunofluorescence
using a monoclonal antibody against NS1. The expansion indices shown were
calculated as the ratio of the percentage of NS1-positive cells in the absence
versus the presence of neutralizing antibody.
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NS2-null mutant (lane 2) or in uninfected controls (lane 1).
However, in cells infected with either of the NS2P or NS2Y
premature termination mutants, P−/Y+ or P+/Y−, these anti-
bodies only detected the remaining isoform (Fig. 2, compare
expression of NS2P only in lane 4, with NS2Y only in lane 3).
Since the termination codon in the NS2P gene, W187am,
should only eliminate 2 amino acids from the extreme C-
terminal of this peptide, the absence of any proteins that reacted
with the anti-P serum in cells infected with this mutant suggests
that, rather than simply being truncated, this gene product fails
to accumulate in vivo. Although the molecular basis for this
defect remains uncertain, such failure of truncated NS2 products
to accumulate has been observed repeatedly in previous studies,
and makes these mutants effectively null for the mutated gene
product (Cotmore et al., 1997; Naeger et al., 1990).
When a similar blot was probed with antiserum directed
against the common amino-terminal peptide shared by NS1 and
NS2 (Fig. 2, lower panel), the failure of truncated NS2 forms to
accumulate became fully apparent. Thus, while NS1 was
present at comparable levels in all infections, NS2 levels
reflected the expected concentrations of the nonmodified
isoforms. Accordingly, no NS2 was detected in the NS2-null
infection (lane 2), while compared to the wildtype infection
shown in lane 5, total NS2 levels in the P−/Y+ (lane 3) and P+/
Y− (lane 4) infections reflected the approximately 1:5 ratio
expected for expression of Y and P isoforms, respectively.
This analysis also showed that, in 324K cells, the adenine-to-
guanine change at nucleotide 1970 reduced NS2 accumulation
levels by 2- to 2.5-fold in each case, while NS1 accumulation
closely resembled that of the wildtype (Fig. 2, bottom panel;
compare lanes 4 and 6, or lanes 5 and 7). Probing with the anti-
NS2P and anti-NS2Y-specific antisera confirmed that Plo/Ylo
expresses both NS2P and NS2Y isoforms, while the Plo/Y−
virus expresses only NS2P.
C-terminally truncated forms of NS1 were found to
accumulate to high levels in 324K cells infected with all virus
genotypes, most notably as two major species of 65 and 45 kDa.
The significance of these NS1 derivatives is currently unknown,
although the 65 kDa form likely corresponds to a similar, but
less abundant and exclusively nuclear species, dubbed NS1*,
previously characterized in MVMp-infected A9 cells (Cotmore
and Tattersall, 1990; Nuesch and Tattersall, 1993).
Mutations within the C-terminal-specific exons of NS2 do not
affect MVM infectivity or its ability to propagate in 324K cells
NS1 expression was also assessed, as a function of input
multiplicity, by immunofluorescence at the individual cell level
in 324K cells, since this provides a useful measure of infection
initiation efficiency. As seen in Fig. 3A, when analyzed 20 h
postinfection, all mutants expressed NS1 in essentially the same
percentage of cells as the wildtype at each input multiplicity.
Additionally, the ability of each genotype to grow productively
in 324K cells was assessed by measuring its spread through the
culture during a 72-h period following infection at low
multiplicity. In this assay, viral fitness is expressed as anexpansion index, which compares the percentage of NS1-
expressing cells present following culture under conditions that
allow cell-to-cell spread, and those that do not. As seen in Fig.
3B, all viral genotypes were able to expand effectively in 324K
cells, although those expressing higher levels of NS2,
specifically the P+/Y− and wildtype viruses, did expand
somewhat more efficiently, consistent with previous reports
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transformed human cell line, NS2-null viruses show a late
defect in progeny virus release (Cotmore et al., 1997) that puts
them at a slight disadvantage relative to wildtype.
Mutations in the C-terminal exons of NS2P and NS2Y also
abolish accumulation of each isoform in A9 mouse cells
Viral nonstructural protein expression profiles in A9
fibroblasts, determined by Western blot analysis 24 h postin-
fection at high input multiplicity (3 × 103 genomes per cell),
generally resembled those seen in 324K cells, again indicating
that introduction of a premature stop codon into the NS2 gene
resulted in failure of that particular product to accumulate in
vivo. Thus, antibodies specific for the NS2P and NS2Ypeptides
failed to detect the mutated products (Fig. 4, top panels), and
antibodies directed against the common N-terminus shared by
NS1 and NS2 generally confirmed that the accumulated
products achieved the levels of expression expected for the
unmodified NS proteins alone. However, because the contribu-
tion of NS2Y to the overall levels of NS2 detected by the anti-
N-terminal NS antibody is relatively minor, it is not possible to
be certain whether the Y183amber mutation present in the P+Y−
virus abolishes accumulation of NS2Y entirely or results in
accumulation of a truncated form of this protein. In contrast to
the expression patterns seen in 324K cells, in A9 cells, the
65 kDa and 45 kDa NS1-related products did not accumulate to
the same high levels, and one mutant, P−/Y+, had an unexpected
effect on NS1 accumulation, as discussed below.
NS2Y expression in the absence of NS2P has a deleterious
effect on NS1 accumulation in mouse cells
Densitometry of the bands in the lower panel of Fig. 4
indicated that the splice mutation at nucleotide 1970 effectivelyFig. 4. Viral protein expression profile in A9 mouse cells. Asynchronous
cultures of A9 cells were infected at a multiplicity of 3000 genomes per cell. At
2.5 h postinfection, the inoculum was removed and medium containing
neuraminidase was added. Uninfected controls and infected cells were harvested
24 h postinfection. Cell pellets were processed for protein analysis following
standard SDS-PAGE and immunoblot protocols. Viral nonstructural proteins
were detected using polyclonal antibodies directed against the C-terminal
hexapeptide sequences specific for NS2P (top panel) or NS2Y (middle panel), or
the common amino-terminus of NS1/2 (bottom panel).reduced the relative accumulation of NS2 species as predicted,
between 5- and 10-fold relative to wildtype. Thus, for the Plo/Y−
mutant, NS2P levels were approximately half the level expected
for NS2Y expression in a wildtype infection. However,
nonstructural gene expression in the complementary experiment
with the NS2P−/Y+ mutant, in which we had expected NS2P
expression to be ablated but the NS2Y isoform to accumulate to
its normal wildtype level, proved more complex. Under the
conditions of this infection, NS1 protein accumulation was
somewhat decreased relative to wildtype in cells infected with
either of the two mutants that lacked the P isoform, NS2-null or
P−/Y+ (compare lanes 2 and 3 with the wildtype infection in
lane 5). Remarkably, however, the mutant that expressed NS2Y
in the absence of NS2P was most severely impaired for NS1
expression. For this mutant, its NS2Y expression level was
much less severely compromised, at about 1.4-fold of the level
achieved for NS2P in the Plo/Y− infection (Fig. 4, compare
lanes 3 and 6). Expression and/or accumulation of the Y isoform
by itself therefore appear to have a deleterious effect on overall
NS protein accumulation, which is most readily apparent at 24 h
postinfection as a defect in NS1 accumulation, which falls 11-
fold relative to wildtype. We conclude that even when viral
genomes are genetically manipulated in such a way that the
NS2P and NS2Y isoforms should theoretically accumulate at
similar rates, stable, exclusive expression of either isoform leads
to very different phenotypes in mouse cells. Specifically,
accumulation of the Y form alone appears to interfere with
normal early gene expression, whereas NS2P, even when
expressed at as little as one-tenth of its normal concentration,
supports normal NS1 accumulation.
Lack of NS2P expression depresses NS1 accumulation in
mouse cells
To explore NS accumulation in mouse cells in greater detail,
we carried out a kinetic analysis in synchronized A9 cells using
wildtype and three mutant viruses, as illustrated in Fig. 5. A9
murine fibroblasts were synchronized in G0 by isoleucine
deprivation and then infected, but arrested, at the G1/S border
by releasing them into complete medium containing the
polymerase inhibitor, aphidicolin (Cotmore and Tattersall,
1987). Cells were harvested 3, 6, and 12 h after aphidicolin
removal, which allowed their release into S-phase. In this
experiment, approximately equimolar concentrations of NS1
and NS2 were readily detected in cells infected with wildtype
virus 3 h after release from the aphidicolin block (Fig. 5, lane 5),
and lesser amounts of both of these proteins were also seen in
the Plo/Y− infection at this time although, as expected, NS1
accumulation exceeded that of NS2P for this mutant (Fig. 5,
lane 4). During the next two time intervals, accumulation of
both proteins continued in cells infected with these two viruses,
with NS2 expression rapidly outpacing NS1 expression in the
wildtype, as expected, but NS1 expression constantly outpacing
NS2 expression in the Plo mutant.
In contrast to NS2P+ infections, NS1 expression was not
detected until 6 h postrelease in cells infected with the NS2-null
and P−/Y+ mutants (Fig. 5, lanes 2 and 3, respectively), and was
Fig. 6. Infection initiation and viral expansion assays in A9 mouse cells. (A)
Asynchronously growing A9 murine cells were infected with NS2-null [◼ ],
NS2P−/Y+ [◊], NS2P+/Y− [□], NS2P+/Y+ (wildtype) [O], NS2Plo/Y− [○], or
NS2Plo/Ylo [•] viruses at a range of multiplicities between 30 and 75,000
genome equivalents per cell, under single cycle infection conditions. Cells were
fixed 20 h postinfection and stained with a mouse monoclonal antibody directed
against the NS1 protein. The percentages of infected cells were calculated as the
ratio of NS1-positive nuclei per total number of DAPI-stained nuclei. (B)
Asynchronous cultures of A9murine fibroblasts were infected at a multiplicity of
30 genomes per cell. At 18 h postinfection, the inoculum was removed and the
cells were incubated with medium in the presence or absence of neutralizing
antibody. At 72 h postinfection, cells were fixed and processed for indirect
immunofluorescence using a monoclonal antibody against NS1. The expansion
indices shownwere calculated as the ratio of the percentage of NS1-positive cells
in the absence versus the presence of neutralizing antibody.
Fig. 5. Kinetics of viral protein expression in A9mouse cells. A9 cell populations
were synchronized by an isoleucine deprivation/aphidicolin double block
procedure. Viruses were added to the cells at a multiplicity of 3000 genomes
per cell in the presence of aphidicolin. Infection times referred to here initiate at
the time of aphidicolin removal, when cells became free to transit into S-phase.
At the indicated times, cells were harvested and processed for SDS-PAGE and
immunoblotting. Viral nonstructural proteins were detected using polyclonal
antibodies directed against the common amino-terminus of NS1/2.
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the experiment. NS2 expression from this mutant was also first
detected at 6 h postrelease, and was approximately equimolar
with NS1 by 12 h into S-phase. Thus, accumulation of the NS
proteins appeared somewhat delayed in both mutants that
lacked NS2P, but in the presence of NS2Y, NS1 levels were
particularly depressed. This suggests that NS2P has an
important impact on early gene expression in MVM, such
that, in its absence, NS1 accumulation is both delayed and
restricted. Notably, comparable levels of NS2Y expression
during this period cannot complement for the absence of NS2P.
Mutants that fail to accumulate NS2P initiate infection in
mouse cells, but are unable to expand through the culture
To follow the course of infection with these mutants, we also
assessed NS1 expression by immunofluorescence at the
individual cell level 24 h postinfection in asynchronous cells,
using this, as before, as a measure of initiation efficiency. As
shown in Fig. 6A, while most mutants appeared to elicit NS1
expression in the same proportion of cells as wildtype virus, theP−/Y+ mutant scored approximately 2-fold lower in this assay at
low multiplicities of infection, between 30 and 1000 genome
equivalents per cell, although its initiation efficiency approached
388 Z. Ruiz et al. / Virology 349 (2006) 382–395wildtype levels at higher input multiplicities. It seems likely that
this deficit simply reflects the diminished levels of NS1
expression observed in these cells, as detailed in Fig. 5, so
that, at low multiplicities of infection, NS1 expression does not
reach the detection limits of the assay in up to half of the cells.
In parallel to these single cycle growth studies, we carried out
the multiple cycle viral expansion assay shown in Fig. 6B, for
each of these viruses in A9 cells. The Plo/Y− mutant was able to
expand almost as efficiently as wildtype virus in A9s, even
though its overall NS2 levels were substantially reduced. In
contrast, both the NS2-null and P−/Y+ mutants showed a defect
of more than 100-fold in viral spread, rendering them effectively
nonviable. Thus, the NS2P isoform performs an essential
function required for MVMp viability in murine cells that
cannot be achieved by equivalent expression of NS2Y alone.
NS2 expression levels modulate progeny genome and capsid
protein accumulation in murine cells
Since the NS2P isoform appears essential for promoting
viability in murine cells, even when expressed at artificially
restricted levels, we explored the effect of suppressing this
isoform on viral DNA replication. For these studies, asynchro-
nous populations of A9 cells were infected at high multiplicity,
under single cycle infection conditions, and harvested 24 h later.
Total cell DNAwas then analyzed on a native agarose gel, and
quantitated by Southern transfer, while culture supernatants
were harvested separately and assessed for progeny virus
release. As seen in Fig. 7A, when analyzed in nondenaturing
agarose gels, monomer and dimer replicative form (RF) DNA
were found to accumulate to similar high levels in A9 cells
infected with viruses that express either normal or reduced
levels of NS2P, although at the lower NS2 levels, accumulation
of both species of RF was 8% to 47% higher than in cells
expressing normal levels of NS2. In contrast, amplification of
RF DNA was almost undetectable in cells infected with either
the NS2-null or the P−/Y+ mutants, indicating that NS2P plays
an essential role in facilitating duplex viral DNA replication.
While the NS2lo mutants gave supra-wildtype levels of
duplex viral DNA, reduced NS2 expression resulted in a ∼13-
fold reduction in intracellular progeny single strand DNAFig. 7. Analysis of viral macromolecular synthesis in A9 mouse cells. A9 murine
fibroblasts were infected at a multiplicity of 10,000 genomes per cell. At 2.5 h
postinfection, the inoculum was removed and medium containing neuramini-
dase was added. Uninfected controls and infected cells were harvested 24 h
postinfection. (A) Total genomic DNAwas extracted and analyzed by Southern
blot as described in the Materials and methods, using a full-length MVM probe.
Monomeric (mRF) and dimeric (dRF) duplex viral replication intermediates and
progeny single-stranded (ss) DNA are indicated. The lower panel shows ssDNA
at 6 times longer exposure than the panel above. (B) Supernatants were
harvested and treated with micrococcal nuclease, proteinase K, and SDS and run
on a 1.4% alkaline agarose gel and processed for Southern blot analysis as
above. The lower panel shows a 25 times longer exposure than the panel above.
(C) The primary and secondary antibodies were removed from the Western blot
shown in Fig. 4 by incubation in stripping buffer for 1 h at 70 °C as described in
the Materials and methods. The membrane was subsequently reblocked and viral
structural proteins were detected using a rabbit polyclonal antibody directed
against the denatured capsid proteins VP1 and VP2.accumulation, compared to wildtype (Fig. 7A, bottom panel).
In addition, accumulation of progeny virus in the culture
supernatant was suppressed somewhat more than 25-fold relative
to wildtype during this period (Fig. 7B). However, as shown in
Fig. 6B, the NS2lo viruses were able to support productive
infection in A9 cells, as measured over the course of 72 h. We
389Z. Ruiz et al. / Virology 349 (2006) 382–395conclude, therefore, that virion production and release do occur
for these viruses, but are merely diminished and kinetically
delayed in the viruses carrying the nucleotide A1970Gmutation.
Thus, the overall concentration of NS2 polypeptide appears to
correlate with the efficiency of progeny virus production.
Since progeny single-stranded DNA only accumulates in
cells that are in the process of assembling competent capsids
(Rhode, 1976; Tullis et al., 1993), and we have previously
shown that capsid assembly is impaired in NS2-null mutant
infections (Cotmore et al., 1997), we reasoned that capsid
protein accumulation and assembly might directly mirror
overall NS2 levels in murine cells. As a first step in assessing
this possibility, we reprobed the Western blot used to assess
NS2 levels in these cells, shown in Fig. 4, with antiserum
directed against denatured MVM capsid proteins. As seen in
Fig. 7C, while viral structural protein (VP) accumulation was
barely detectable 24 h following infection with the NS2-null or
P−/Y+ viruses, in A9 cells infected with wildtype, NS2P+/Y−,
and NS2Plo viruses, VP accumulation appeared to be
proportional to the level of NS2 present, densitometric analysis
indicating that the 5–10-fold decrease in NS2 production by the
NS2lo viruses, seen in Fig. 4, was accompanied by a 4- to 6-fold
decrease in VP accumulation by this time during infection.
Despite reduced capsid protein accumulation, low level
expression of NS2 supports capsid assembly in murine cells
Since the level of NS2 expression appeared to correlate with
capsid protein accumulation, at least late in infection, we further
explored the effects of restricted NS2 expression on capsid
expression and assembly at an earlier time point in infection,
this time by confocal microscopy. For these studies, A9 cell
populations were infected with wildtype, NS2-null, NS2P−/Y+,
or NS2Plo/Y− viruses and synchronized as described for Fig. 5.
Cells were fixed 10 h following aphidicolin removal, i.e. 10 h
into the S phase of the cell cycle, and infection was assessed by
confocal imaging of immunofluorescent-infected cell prepara-
tions. As mentioned previously and illustrated in Fig. 8A, a
qualitative difference in NS1 accumulation was readily apparent
between cells infected with NS2P-null mutants and those
expressing the NS2P isoform, even at the diminished levels seen
in NS2Plo/Y−. Specifically, in the absence of NS2P, NS1Fig. 8. Analysis of capsid assembly in synchronized A9 mouse cells. Semi-
confluent A9 cell monolayers were synchronized and infected as described in
Fig. 5 and in the Materials and methods. At 10 h following aphidicolin removal,
cells were fixed and processed for differential immunofluorescence analysis
with antisera recognizing NS1, VP structural proteins, or assembled capsid
particles, as indicated. Confocal micrographs were taken with a 63× objective,
of infected synchronized A9 cells, costained with, in panel A, antisera directed
against NS1 and assembled capsid particles or, in panel B, antisera directed
against VP proteins and assembled capsid particles. The composite photo-
micrographs shown in panel B are images of individual cells from separate
microscopic fields. Because of the lower VP expression levels per cell obtained
with the NS2P−/Y+ mutant, the images have been contrast-enhanced in
Photoshop, in order to enable comparison with the NS2Plo/Y− mutant. Both
anti-VP and anticapsid images were enhanced equally. (C) Capsid assembly was
measured as the percent NS1-positive staining cells that also stained positive
with a mouse monoclonal antiserum directed against assembled capsid particles.staining was invariably restricted to a number of small punctate
foci, whereas in the presence of NS2P, NS1 commonly occupied
much larger foci or was distributed almost uniformly through-
out the nucleus. The significance of this disparity is currently
under further investigation.
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mined in these cells, staining for VP expression with rabbit
antiserum directed against denatured capsid proteins and for
assembly with monoclonal antibodies that only recognize intact
particles. As illustrated in the confocal images of the Plo/Y− and
P−/Y+ viruses seen in Fig. 8B, at this early time point, capsid
proteins could be detected with the anti-VP antibodies in cells
infected with all viruses, although the levels of staining intensity,
and hence the levels of VP accumulation, varied in accordance
with the immunoblot data shown for NS2Plo/Y− and NS2P−/Y+
mutants in Fig. 7C. In general, while mouse cells infected with
wildtype virus displayed the most intense staining, the lowest
levels of VP protein immunofluorescence were seen in cells
infected with the NS2-null and NS2P− mutants, and cells
infected with the NS2Plo mutants displayed an intermediate
intensity (Fig. 8B and data not shown). However, costaining
with the antibody directed against assembled particles demon-
strated that while a large proportion of VP-positive cells infected
with theNS2Plo mutant were able to assemble particles (Figs. 8A
and B, upper panels), cells infected with NS2P− viruses
appeared unable to assemble viral particles efficiently (Figs.
8A and B, lower panels). To quantitate this defect, we calculated
an “assembly index” by comparing the proportion of cells
expressing NS1 with those showing evidence of capsid
assembly. When compared to wildtype virus, NS2-null and
NS2P− viruses exhibited a 30-fold defect in capsid assembly, as
shown in Fig. 8C. Remarkably, this analysis also suggested that,
although the Plo/Y− mutant appeared to accumulate VP proteins
somewhat less efficiently than wildtype virus, capsid assembly
was apparent in a higher proportion of infected cells. Thus, the
reduced level of progeny single-strand DNA synthesis observed
in cells infected with Plo/Y− virus, shown in Figs. 7A and B,
does not appear to correlate with a specific defect in capsid
assembly.
Discussion
Previous analyses of NS2 have established the importance of
this nonstructural polypeptide for MVM propagation in murine
cells (Cotmore et al., 1997; Naeger et al., 1990). Here, we extend
these studies by examining the potentially disparate roles played
by its two major spliced variants, NS2P and NS2Y. These
proteins do not appear to play a significant role in the initial
stages of infection that precede viral gene expression, such as
receptor binding, cell entry, or trafficking to the nucleus.
However, in this report, we demonstrate that in murine cells
NS2 is involved in at least two stages of the ensuing infectious
process, one occurring early in the expansion of viral replication
foci, for which theNS2P isoform is absolutely required, while the
second manifests as an NS2 dosage effect, in which the overall
level of NS2 modulates the extent of progeny genome synthesis.
NS2 levels modulate the generation of progeny genomes in
murine cells
The NS2lo mutation involves an A1970G nucleotide change
in the putative branch point of the major MVM intron, whicheffectively decreases the overall expression of NS2 relative to
NS1, presumably through its modulation of the splicing event
that generates the R2 transcript from which the NS2 polypep-
tides are translated (D'Abramo et al., 2005; Choi et al., 2005).
Viruses with this mutation initiate infection at levels that are
comparable to wildtype in both murine A9 and transformed
human 324K cells, and can be propagated in both cell types, but
despite efficient duplex viral DNA amplification in mouse cells,
there is a significant decrease in the number of progeny single-
stranded genomes generated. Although NS1 is involved in
multiple aspects of viral DNA replication, no direct role for NS2
has been identified in this process. However, duplex forms of
viral DNA ultimately accumulated to somewhat higher levels in
cells infected with the NS2lo mutants than in wildtype
infections. This is consistent with a model for packaging that
we have recently proposed (Cotmore and Tattersall, 2005), in
which displaced single-strands are withdrawn from the
replicating pool by the encapsidation machinery, dependent
upon the availability of packaging-competent capsids. Since the
terminal nature of packaging renders it effectively as a first-
order process, while replication is inherently geometric, we
propose that a mechanism must exist that restrains ongoing
packaging from inhibiting the exponential accumulation of
duplex viral DNA at early times. If this is the case, it follows
that there is likely a switch that releases precursor capsids from
such a “restrained” state. If such a switch were to require a
critical level of NS2, then the slower accretion of NS2 in NS2lo
mutant infections would delay and reduce packaging, while
coincidentally leading to the higher levels of viral duplex DNA
accumulation we observed.
However, the impact of reduced NS2 levels could also be
manifest through more indirect routes. For example, the fact that
NS2 is required for efficient capsid assembly in A9 cells
(Cotmore et al., 1997) may be directly relevant in switching
DNA replication to progeny synthesis, because this is
dependent upon the availability of assembled capsids (Rhode,
1976; Tullis et al., 1993). In the present study, we use
immunofluorescence staining with structure-specific antibodies
to demonstrate that some particle assembly does occur in A9
cells infected with NS2lo mutants, but this type of assay is
poorly quantitative, so that the efficiency of the assembly
process could vary with the availability of NS2. We also show
that reduced NS2 expression correlates with diminished capsid
protein accumulation in these cells. While this may suggest a
direct effect of NS2 on the synthesis of structural polypeptides,
it could also reflect defective assembly, since when A9 cells
were infected with NS2-null mutants, unassembled VP proteins
initially accumulated, but appeared then to be turned over faster
than they were synthesized, rather than to be assembled into
intact capsids (Cotmore et al., 1997). Current studies are
directed at distinguishing between these two possibilities.
The A1970G mutation is one of approximately 150 single
base changes that exist between MVMi, the lymphotropic strain
of MVM, and MVMp, the fibrotropic strain used here. These
viruses are reciprocally restricted for growth in each other's
productive host cell type. However, a number of host range
mutants of MVMi have been selected, which have either gained
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their tropic phenotype, by acquiring two mutations in the coat
protein gene. Possibly, this means that two coordinated changes
in capsid structure are required to switch tropism while
maintaining the integrity of the particle. Such host range
mutants still possess the G nucleotide present in the MVMi
genome at position 1970. This leads to expression levels for
NS2 that appear suboptimal for growth in A9 cells, since further
nucleotide changes that upregulate NS2 synthesis can rapidly be
selected following passage in these cells. However, we have
recently described two host range mutants, hr105 and hr107,
which became fibrotropic as the result of a single amino acid
change in the VP2 gene, D399A, and D399G, respectively. In
each case, this change was accompanied by a single nucleotide
change, near the putative branch point of the major intron,
G1970A and G1967A, respectively, that led to enhanced NS2
expression (D'Abramo et al., 2005). When introduced as single
mutations into the MVMi backbone, each single VP2 amino
acid change allowed the virus to initiate infection in A9 cells,
but they remained defective in progeny production and were
unable to spread through the culture. However, addition of
either putative branch point mutation relieved this block,
creating a potent fibrotropic virus. Thus, while the D399A or G
amino acid change by itself was able to reverse the host range
defect of MVMi for initiating infection in A9 fibroblasts, it
appeared to generate a virus with such impaired fitness that it
could only propagate in cells that expressed high levels of NS2.
This may suggest that suboptimal capsid structures are
particularly dependent upon high level expression of NS2,
and tend to indicate that a capsid assembly defect could well
underlie the D399A/G phenotype.
Finally, reduced progeny synthesis in NS2lo infections of
mouse cells could reflect some form of inhibition resulting
either from nuclear retention of the nuclear export protein,
Crm1, or from the restricted cytoplasmic export of full virions.
Nuclear export of mature viral particles in A9 cells is regulated
by an interaction between NS2 and Crm1 (Eichwald et al.,
2002; Miller and Pintel, 2002), which maps to NS2 amino acids
81–103, located in the second exon that is shared by all three
NS2 isoforms. Moreover, MVM mutants with impaired NS2-
Crm1 binding sites show both restricted egress of DNA-
containing virions from the nucleus, and a reduction in the
accumulation of progeny single strands (Eichwald et al., 2002;
Miller and Pintel, 2002). Recently, it has also been reported that
low NS2 expression correlates with impaired progeny DNA
synthesis following transfection of MVMi into A9 cells, and
that this defect can be overcome by a mutation that increases the
strength of the NS2–Crm1 interaction (Choi et al., 2005; Lopez-
Bueno et al., 2004). Thus, it seems possible that the minimal
NS2 levels produced by NS2lo viruses could limit both the rate
of Crm1 removal from the nucleus and the rate of virion export.
The molecular basis for such putative feed-back inhibition
remains uncertain, but it is possible that full virions might
compete for factors required for assembly or packaging, or
might somehow impede single strand displacement synthesis,
so that their removal would facilitate further progeny produc-
tion. Alternatively, limited removal of Crm1 from the cellnucleus may allow it to dominate nuclear trafficking. Accord-
ingly, MVMi viruses with a variety of mutations that enhanced
NS2–Crm1 binding showed enhanced Crm1 sequestration in
the perinuclear cytoplasm, which was associated with the early
release of NS1 and empty capsids from the nucleus and an
accelerated viral life cycle (Lopez-Bueno et al., 2004).
NS2P performs a critical function in the establishment of a
productive replicative compartment that supports MVM DNA
replication
Time course analysis of viral protein expression in
synchronized cells revealed that, in wildtype infections, NS2
is the predominant virally coded protein expressed during the
first few hours of S-phase, but that, in the absence of NS2P, but
not of NS2Y, there is a significant delay in the onset of all NS
gene expression, followed by diminished long-term accumula-
tion of NS1. This suggests that NS2P critically impacts a very
early step in viral amplification at a time when it is normally
made available at high copy number in the newly infected cell.
Expressed in this way, NS2P might play an essential indirect
role in early stages of the viral life cycle by creating a cellular
environment that in some way supports viral, rather than
cellular, DNA synthesis and/or transcription. The other early
viral protein, NS1, is a multifunctional nuclear phosphoprotein
that initiates and orchestrates viral DNA replication, but its
replicative functions are themselves regulated by specific
phosphorylation events (Nuesch et al., 1998a, 1998b). Thus,
if NS2P activated cellular enzyme pathways that ensured the
correct posttranslational modification of NS1, it could greatly
enhance subsequent viral amplification. On the other hand, any
restriction in early viral DNA replication might limit the
generation of additional viral transcription templates, ultimately
resulting in diminished accumulation of all viral genes, as seen
in the NS2P− mutant infections. Remarkably, only the NS2P
isoform appears to be capable of making this critical early, but
as yet unidentified, interaction, and can do this even when
expressed at approximately one tenth of its normal concentra-
tion. In contrast, NS2Y cannot substitute for NS2P, and when
expressed alone may even have a negative impact on NS1
expression and viral fitness.
In addition to the lower overall expression of NS1 seen in
NS2P− infections of murine cells, immunofluoresence analysis
showed that the NS1 staining pattern was consistently different
in cells infected with P−/Y+ and Plo/Y− viruses. Whereas NS1
occupies most of the nucleoplasmic space in both wildtype- and
Plo/Y−-infected cells by 10 h postrelease, in both NS2-null and
P−/Y+-infected cells, it remains within small distinct nuclear
puncta that are normally only apparent at very early time points
in wildtype infection, suggesting that, in the absence of NS2P,
these foci fail to mature. Punctate intranuclear inclusions of this
type are termed autonomous parvovirus-associated replication
(APAR) bodies, since they have been shown to be the sites of
active viral DNA replication (Bashir et al., 2001; Cziepluch et
al., 2000). Our preliminary kinetic analysis of wildtype MVMp-
infected A9 cells suggests that APAR bodies undergo an orderly
progression through identifiable stages of maturation, all but the
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infected with NS2P− viruses, even when these are analyzed 24 h
postinfection at high multiplicities of infection in synchronous
cultures.
These observations suggest that the synthesis and organiza-
tion of viral macromolecules become progressively paralyzed
during infection of A9 cells in the absence of NS2P. One possible
explanation for this result would be that APAR body
progression, as well as all other viral functions, arrests early in
S-phase due to the triggering of an antiviral state or cell death
pathway that is normally interdicted byNS2P. Parvoviruses have
been reported to elicit a variety of cell death pathways, most
commonly through expression of their NS1 protein, but these
can be remarkably disparate in different cell types. For example,
the human erythrovirus, B19, induces a caspase 9-dependent
apoptotic pathway in primary hepatocytes and Hep G2 cells
(Poole et al., 2004), but a caspase 8-mediated TNFα pathway in
the human monocytic cell line U937 and in cells of the erythroid
lineage (Sol et al., 1999; Fu et al., 2002). Similarly, H-1 has been
shown to induce classical apoptosis in U937 cells (Rayet et al.,
1998) and in rat glioblastoma cells and newborn rats (Ohshima et
al., 1998). However, in both transformed human keratinocytes
and rat fibroblasts, H-1 infection disrupts energy metabolism
through depletion of intracellular NAD pools and trigger
morphologic changes that are consistent with necrotic/oncotic
cell death (Ran et al., 1999). Thus, rather than inducing a virus-
specific pathway, it is possible that parvovirus-infected cells
simply die by their default death pathway, which may be
apoptosis, oncosis, autophagy, or perhaps a cell-type-specific
variation on one of these. In MVM-infected 324K cells, nicks
accumulate in the cellular chromatin in an NS1-dependent
fashion (Op de Beeck and Caillet-Fauquet, 1997), while MVM-
infected transformed rat fibroblasts are arrested in either the S or
G2 phases of the cell cycle. The S-phase arrest was shown to be
p53-, but not p21cip1, dependent, whereas the G2 arrest required
both p53 and p21cip1, with p21cip1 appearing to operate through
inhibition of cyclin A-dependent kinase activity (Op de Beeck et
al., 2001). Nevertheless, despite this wealth of information, at
present, we have little information about how MVM elicits cell
death in infected A9 cells, or whether NS2 can interfere with the
process. As part of this study, we have examined asynchronous
A9 populations infected with various NS2 mutant viruses for
markers of apoptosis, but were unable to demonstrate external-
ization of phosphatidylserine on the outer leaflet of the plasma
membrane with fluorescent annexin V, or the cleavage of the
cellular DNA repair protein poly-(ADP-ribose)-polymerase,
indicating that classical apoptotic pathways are probably not the
major cytolytic mechanism triggered in such infections. Thus, a
more careful analysis will be required to explore a possible role
for NS2P in interdicting a nonapoptotic cell paralysis in A9 cells.
The possibility that NS2P plays a positive regulatory role in
MVM infection in A9 cells has to be viewed from the
perspective that an activity present in human 324K cells can
complement this function in the absence of the NS2P isoform. It
seems unlikely that a mouse virus would have evolved to be
able to use a human factor but not its murine equivalent, unless
expression of this factor is unique to human cells. Such a factormight be induced by transformation, or indeed a component
expressed by the transforming SV40 viral genome itself.
Mitigating against such a conclusion is the observation that
MVM growth is also abrogated by NS2 loss in papovavirus-
transformed rodent cell lines (Cater and Pintel, 1992). We
therefore favor the idea that NS2P might interdict a specific
cellular response to infection, and that this response is fatally
compromised by one of the events leading to neoplastic
transformation in human, rather than rodent, cells (Hahn and
Weinberg, 2002).
While the specific mechanism by which NS2 carries out its
essential role is not understood, previous studies, as well as those
reported here, indicate that NS2 plays multiple and complex
roles during MVM replication in murine cells. Analysis of
protein expression in murine cells infected with the P−/Y+ and
Plo/Y− mutants demonstrates that these viruses accumulate
similar levels of NS2. However, it is only when the NS2P
isoform fails to accumulate, as in the case of the P−/Y+ virus, that
viral replication is reduced more than 100-fold, effectively
rendering this virus nonviable in these cells. Comparison of the
two NS2lo viral mutants, either expressing or not expressing the
NS2Y isoform, demonstrates that the levels of DNA replication,
capsid protein accumulation, and viral dissemination are not
affected by the minor spliced variant, NS2Y. Together, these
results suggest that NS2P may play a positive regulatory role in
MVM replication in A9 cells. However, it is currently unclear
whether the requirement for NS2P reflects a need to abrogate an
antagonistic effect on viral replication carried out by the NS2Y
C-terminus in trans, in a way that can be titrated by excess full-
length or truncated non-NS2Y isoforms.
As the data presented herein support the conclusion that the
NS2P splice variant performs an essential role for virus
replication in murine cells, this is not necessarily the case for
the NS2-2381 mutant, described previously, that bears an ochre
(oc) premature termination codon at E184 of the NS2P-specific
C-terminus (Naeger et al., 1990). We have reconstructed this
mutant in our wildtype background, and preliminary studies
support the previously published observations with this mutant
(Naeger et al., 1990). In contrast to our observations for the P−/
Y+ virus, the E184oc mutant does produce a stable truncated
protein in both A9 cells (our data, not shown) and in 324K as
previously reported (Naeger et al., 1990). Unlike the P−/Y+
mutant, which displays a more than 100-fold defect relative to
the wildtype in expansion throughout a culture of murine cells,
the E184oc mutant displays only a 3- to 4-fold decrease (data
not shown), comparable to the expansion levels we observed for
the NS2lo mutants, and consistent with the 3-fold defect in
plaquing described previously (Naeger et al., 1990). The basis
for the pleiotropic effects of mutations in NS2P on MVM
replication in A9 cells is not known. However, the viability of
E184oc, which expresses the body of NS2 and terminates with
the first proline residue within the NS2P-specific exon, suggests
an alternative, and more complex scenario, in which the NS2Y
isoform may possibly be unable to execute the essential
function of NS2 due to the inactivation, in cis, of an essential
activity of the common NS2 domain, by the C-terminal
YDGASS hexapeptide. In this scenario, virus viability would
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only available as NS2P, present within the cell. Ongoing studies
of the replication and expansion of MVM mutants that
accumulate truncated versions of NS2 in the absence of the
NS2Y isoform, as well as the behavior of NS2 knockouts in
stable cell lines expressing either NS2 isoform on its own,
should allow us to distinguish between the different possibilities
for the essential function of NS2 in murine cells.
Materials and methods
Construction of NS2 mutants
The NS2− mutant genomes were constructed in the
infectious cloned form of the prototype virus MVMp by PCR-
mediated mutagenesis. To create P−/Y+, the tryptophan codon at
residue 187 of NS2P was changed, from TGG to TAG, in a
PCR-generated StuI fragment, which was used to replace the
StuI fragment between nucleotides 2377 and 2501 of theMVMp
infectious clone pMVMp-D1 (Gardiner and Tattersall, 1988).
For the construction of P+/Y−, the tyrosine codon at residue 183
of NS2Y was changed from TAC to TAG by PCR, the product
digested with XhoI and NarI, and used to replace the XhoI to
NarI fragment (MVM nts 2070 through 2289) of pULB3224.
This plasmid was then digested with EcoRI and the internal
fragment (MVM nts 1084 through 3522) was transferred into
pMVMp-D1. To create Plo/Ylo, the nucleotide at position 1970
was changed from A to G by chimeric PCR. The final PCR
product was digested with BstEII and XhoI and used to replace
the BstEII (1884) to XhoI (2070) fragment of pMVMp-D1. To
create Plo/Y−, the Plo/Ylo plasmid was digested with BstEII and
XhoI and the fragment was used to replace the BstEII to XhoI
fragment of the P+/Y− plasmid. NS2-null is the NS2 F86am
mutant described previously (Cotmore et al., 1997).
Cells and viruses
The wildtype strain of MVMp and its mutant derivatives
were propagated in the SV40-transformed newborn human
kidney cell line 324K. Cells were cultured and maintained in
Dulbecco's modified Eagle's minimal medium (DMEM)
containing 5% fetal bovine serum. Viruses were initially
recovered from infectious plasmids by Superfect (Qiagen)-
mediated transfection of 324K monolayers.
Viral stocks were quantitated and standardized by Southern
blot against known amounts of genome-length viral DNA.
These stocks were used to infect asynchronous cultures of 324K
cells or the mouse L-cell derivative, A9 ouabr11, as stated in the
text. In some experiments, A9 cell populations were synchro-
nized by an isoleucine deprivation/aphidicolin double block
procedure as described previously (Cotmore et al., 1997).
Briefly, cells were allowed to accumulate in G0 by depriving
them of isoleucine for 48 h. They were then allowed to progress
to the G1/S boundary by incubating the cultures in medium
containing isoleucine and 10 μg/ml of the DNA polymerase
inhibitor aphidicolin, for 20 h. Viruses were added to the cells at
a multiplicity of 3000 genome equivalents per cell in thepresence of aphidicolin. The viruses were able to enter the cells
and accumulate within the nucleus at an immediately pre-DNA
synthetic step in the viral life cycle prior to removal of the
inhibitor. Infection times initiate at the time of aphidicolin
removal, when the cells became free to transit into the S-phase.
For confocal microscopy, A9 cells were seeded onto round
coverslips in 35-mm dishes at a density of 2.9 × 105 cells per
dish and synchronized as described above. At the indicated time
following aphidicolin removal, cells were fixed onto the
coverslips in 2.5% paraformaldehyde and permeabilized in a
1% NP-40 solution prepared in PBS. Coverslips were incubated
with antisera recognizing NS1, VP structural proteins, or
assembled capsid particles.
Infection initiation assay
Semi-confluent monolayers of transformed human 324K
cells or A9 cells were infected at a range of multiplicities
starting at 75,000 genome equivalents per cell and ending at
approximately 30 genome equivalents per cell for 3 h at 37 °C.
The inoculum was subsequently removed and the cells were
supplemented with medium containing neuraminidase. Cells
were fixed in 2.5% paraformaldehyde at 20 h postinfection.
Following permeabilization in 0.1% Triton X-100, cells were
stained with a mouse monoclonal antibody against the NS1
protein. The percentages of infected cells were calculated as the
ratio of NS1-positive nuclei per total number of DAPI-stained
nuclei.
Viral expansion assay
Viral expansion was assessed as described previously (Farr
and Tattersall, 2004) with slight modification. Briefly, cells
were infected at a multiplicity of 30 genome equivalents for 3 h
after which the inoculum was removed and the cells were
supplemented with DMEM containing 5% fetal bovine serum.
At 18 h postinfection, the medium was removed and replaced
with regular medium or medium containing a neutralizing
anticapsid antibody. Cells were fixed 72 h postinfection and
stained with a mouse monoclonal antibody against NS1. The
expansion index was calculated as the ratio of the percentages of
infected cells in the presence versus the absence of neutralizing
antibody.
Analysis of viral protein accumulation
Cells were infected at amultiplicity of 3000 genome equivalents
per cell for 2.5 h. Subsequently, the virus-containing media were
removed and replaced with DMEM containing 5% FBS and
neuraminidase. At 24 h postinfection, cells were harvested by
scraping into themedium. After centrifugation, the cell pellets were
drained, resuspended in phosphate-buffered saline (PBS) contain-
ing a protease inhibitor cocktail, and flash-frozen on dry ice. For
analysis, pellets were solubilized from the frozen state by rapid
boiling in SDS sample buffer and fractionated by electrophoresis
on 11% polyacrylamide gels. Proteins were transferred onto
PVDF membranes following standard protocols. Blots were
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peptide common to both NS1 and NS2 or with peptide-specific
rabbit antiserum directed against the C-terminal peptide of the
NS2P and NS2Y isoforms. In one instance, the membrane was
stripped of bound antibodies by incubation in stripping buffer
(100mM2-Mercaptoeathanol, 2% SDS, 62.5mMTris–HCl, pH
6.8) for 1 h at 70 °C. The membrane was subsequently reblocked
and probed with a rabbit antiserum directed against denatured
MVM capsid polypeptides. Proteins were detected using an
HRP-conjugated secondary antibody followed by enhanced
chemiluminescence.
Analysis of viral replicative form DNA
Cells were infected at a multiplicity of 10,000 genomes per
cell in duplicate samples. The inoculum was removed and
harvested 6 h postinfection and fresh medium containing
neuraminidase was added to the cells. At 24 h postinfection,
cells were harvested and wildtype and mutant MVM
replication forms produced during infection were visualized
by Southern blot analysis of total cell extracts as previously
described (Cotmore et al., 1997).
Detection of packaged viral DNA
Culture supernatant from infected cells was collected and
digested sequentially with micrococcal nuclease (0.4 μg/μl) for
30 min, proteinase K (0.7 μg/ml) for 30 min, and 0.5% SDS for
15 min. All reactions were carried out at 37 °C. Samples were
then exposed to 0.3 M NaOH and run on a 1.4% alkaline gel
followed by Southern blotting on to Zeta-Probe GT membrane
(Bio-Rad Laboratories, Hercules CA). DNAwas cross-linked to
the membrane by UV irradiation and hybridization performed
with a random primed (Roche Diagnostics Gmb) MVM DNA
probe that detects the entire genome.
Confocal imaging
After immunostaining and mounting, specimens were
analyzed by confocal laser microscopy (LSM 510) using a
63× objective. FITC and rhodamine signals were detected using
the 488- and 568-nm excitation lines of an argon–krypton laser.
Images were acquired and modified with the LSM 510 software
version 2.8 and Adobe Photoshop.
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